FDA Meeting Will Spotlight “Challenges” With Cannabis Compounds in Foods and Supplements

The meeting, which will use cannabinoids as a “case study” in assessing the “safety” of certain foods and supplements, comes as the FDA wrestles with rulemaking for CBD products.


Hemp Policy Item Tabled Amid Concerns at Meeting of U.S. Ag Regulators

Citing concerns about hemp used as cover for higher-THC cannabis, a NASDA policy committee tabled a proposal to lift some requirements for industrial hemp.


FDA nabs new cannabis advisor • Canopy divests from retail in Canada • Illinois’ cautionary tale on equity

An excerpt from recent editions of the Cannabis Wire Daily newsletter.